AUA 2017 Annual Meeting Worse Survival After Robotic Cystectomy Seen at Low-Volume Centers

Worse Survival After Robotic Cystectomy Seen at Low-Volume Centers

The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.

AUA 2017 Annual Meeting MRI Accuracy for Prostate Cancer Challenged

MRI Accuracy for Prostate Cancer Challenged

Systematic biopsies always should be performed in conjunction with targeted biopsy in men with suspected clinically significant PCa at mpMRI.

AUA 2017 Annual Meeting Novel PSA Assay Improves Prostate Cancer Diagnosis

Novel PSA Assay Improves Prostate Cancer Diagnosis

The new test, IsoPSA, measures all PSA isoforms in serum and more accurately discriminates high-grade cancer from benign disease.

AUA 2017 Annual Meeting Pure Bladder Cancer Variants Linked to Worse Survival After RC

Pure Bladder Cancer Variants Linked to Worse Survival After RC

Patients with a pure variant had significantly lower survival odds than those with pure urothelial carcinoma over a median 6.5 years of follow up.

AUA 2017 Annual Meeting Real-World mUCB Patient Survival Worse Than in Clinical Trials

Real-World mUCB Patient Survival Worse Than in Clinical Trials

Just 1 in 4 patients diagnosed with metastatic urothelial carcinoma of the bladder survive for a year, according to US national registry data.

AUA 2017 Annual Meeting Robot-assisted Radical Cystectomy on the Rise

Robot-assisted Radical Cystectomy on the Rise

By 2014 to 2015, 1 in 3 bladder cancer surgical procedures performed in the United States were robot-assisted.

AUA 2017 Annual Meeting Neoadjuvant Chemo Benefits Some Variant MIBC Patients

Neoadjuvant Chemo Benefits Some Variant MIBC Patients

Researchers find prolonged survival among patients with neuroendocrine muscle-invasive bladder cancer.

AUA 2017 Annual Meeting Post-chemo PD-L1 Tied to Worse Prognosis in Bladder Cancer Pts

Post-chemo PD-L1 Tied to Worse Prognosis in Bladder Cancer Pts

Five-year cancer-specific survival rates were 48.1% and 69.6% for PD-L1 positive and negative patients, respectively.

AUA 2017 Annual Meeting AUA Releases Updated Renal Mass Guidelines

AUA Releases Updated Renal Mass Guidelines

The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance.

AUA 2017 Annual Meeting PCa Active Surveillance Safe, Effective for Younger Patients

PCa Active Surveillance Safe, Effective for Younger Patients

A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.

AUA 2017 Annual Meeting MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

MRI-Fusion Biopsy Benefits PCa Active Surveillance Patients

Targeting PI-RADS 4 and 5 lesions for confirmatory biopsy improves detection of clinically significant cancer.

AUA 2017 Annual Meeting Sipuleucel-T Survival Benefit Greater in Blacks

Sipuleucel-T Survival Benefit Greater in Blacks

Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.

AUA 2017 Annual Meeting Low Testosterone Increases Women's Urinary Incontinence Risk

Low Testosterone Increases Women's Urinary Incontinence Risk

Lowest quartile of serum testosterone is associated with 48% and 65% increased odds of stress and mixed urinary incontinence, respectively.

AUA 2017 Annual Meeting Fusion Biopsy Ups Detection of Clinically Significant PCa

Fusion Biopsy Ups Detection of Clinically Significant PCa

Fusion biopsy has improved over the last decade and increasingly detects clinically significant prostate cancer, according to data trends from one institution.

AUA 2017 Annual Meeting Prostate Photovaporization for BPH Beneficial Long-Term

Prostate Photovaporization for BPH Beneficial Long-Term

Average International Prostate Symptom Score remained low 5 years after the PVP laser procedure.

AUA 2017 Annual Meeting New-Onset Urinary Incontinence Common After HoLEP for BPH

New-Onset Urinary Incontinence Common After HoLEP for BPH

Researchers identified a predictor of new-onset UI after HoLEP that may aid urologists in clinical practice.

AUA 2017 Annual Meeting Water Vapor Ablation Eases BPH-Related Urinary Retention

Water Vapor Ablation Eases BPH-Related Urinary Retention

In a study, 81.1% of men were able to void after an average of 28 days after treatment.

AUA 2017 Annual Meeting Prostate Cancer Distant Metastasis Predicted by APV

Prostate Cancer Distant Metastasis Predicted by APV

Highest quartile of alkaline phosphatase velocity in men who experience biochemical recurrence after radical prostatectomy is associated with 2-fold higher risk.

AUA 2017 Annual Meeting Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

Non-index Lesions at Biopsy Help Predict Adverse RP Outcomes

Systematic biopsy parameters identified patients at higher risk of positive surgical margins.

AUA 2017 Annual Meeting Bladder Cancer Survival Worse Among Women Despite RC

Bladder Cancer Survival Worse Among Women Despite RC

Among stage 2 to 4 bladder cancer patients, women had lower cancer-specific survival than men.

Sign Up for Free e-newsletters